Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Leverage Emerging Pathways for Access Manufacturers must adapt and respond to increasing budget impact pressure for key access stakeholders and potential therapy restrictions implemented by emerging PBM/ coverage models
Steens J, Van Der Schaar PJ, Penning C, Brussee J, Masclee AA
Int J Mol Sci 2022;23:14631.ArticlePubMedPMC 86
[16] [18] Ascorbic acid crosses the placenta and is excreted in breast milk
Zhao H, Zhang J, Cheng X, Nie X, He B (2023) Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment
US$ 23.89
US$ 27.53
US$ 29.35
US$ 23.28
US$ 20.03
US$ 23.82
US$ 23.10
